Loading...

APGE APOGEE THERAPEUTICS INC US FDA Inspections 8-K Filing

PG T

PG

APOGEE THERAPEUTICS INC

(APGE)

2025 8-K

Show Summary

Show Summary

Clinical Trials

Financial Results

Clinical Trial Update

Clinical Trial Launch

Financial Results

Clinical Trial Update

Clinical Trial Launch

Financial Results

Meeting Results

Appointment of Director

Earnings Report

Presentation of Phase 1 Data

Financial Results and Phase...

Financial Results Announcement

Appointment of Mark C. McKe...

External Links:

Apogee Therapeutics, Inc. reported positive interim results from its Phase 1b trial of APG808 and shared its financial results for the quarter ending March 31, 2025, on May 12, 2025.

AI Assistant

APOGEE THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.